| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBR.2006.05.029 |
| P698 | PubMed publication ID | 16857277 |
| P2093 | author name string | Toshitaka Nabeshima | |
| Akira Nakajima | |||
| Kiyofumi Yamada | |||
| Atsumi Nitta | |||
| Yijin Yan | |||
| Tomoko Mizuno | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | morphine | Q81225 |
| P304 | page(s) | 39-46 | |
| P577 | publication date | 2006-07-20 | |
| P1433 | published in | Behavioural Brain Research | Q3619047 |
| P1476 | title | Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds. | |
| P478 | volume | 173 |
| Q41444993 | A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus |
| Q35679955 | Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats |
| Q27026759 | Dopamine D4 receptors in psychostimulant addiction |
| Q28752585 | Endogenous opiates and behavior: 2006 |
| Q36672658 | Glial cell modulators attenuate methamphetamine self-administration in the rat. |
| Q28307030 | Glial modulators as potential treatments of psychostimulant abuse |
| Q33896124 | Identification of a new selective dopamine D4 receptor ligand |
| Q42365240 | Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities |
| Q45068639 | Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence |
| Q41902714 | The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release |
| Q33886313 | The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse |
| Q37681020 | The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice |
Search more.